Research Topics
| Martin B KellerSummaryAffiliation: Brown University Country: USA Publications
| Collaborators
|
Detail Information
Publications
The long-term clinical course of generalized anxiety disorderMartin B Keller
Department of Psychiatry, Brown University, Providence, RI 02906, USA
J Clin Psychiatry 63:11-6. 2002....
The naturalistic course of unipolar major depression in the absence of somatic therapyMichael A Posternak
Brown University School of Medicine, Department of Psychiatry and Human Behavior, Providence, Rhode Island, USA
J Nerv Ment Dis 194:324-9. 2006..Because treatment-seeking behavior is known to be associated with a worse prognosis, 23 weeks probably represents a lower-limit approximation of the median duration of an untreated depressive episode...
Factors associated with the persistence and onset of new anxiety disorders in youth with bipolar spectrum disordersRegina Sala
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
J Clin Psychiatry 73:87-94. 2012..Anxiety disorders are among the most common comorbid conditions in youth with bipolar disorder, but, to our knowledge, no studies examined the course of anxiety disorders in youth and adults with bipolar disorder...
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depressionAlan J Gelenberg
Department of Psychiatry, Health Sciences Center, University of Arizona, PO Box 245002, Tucson, AZ 85724-5002, USA
Biol Psychiatry 54:806-17. 2003..8%). Somnolence was significantly greater among the patients taking active medication (15.4%), compared with placebo (4.6%). CONCLUSIONS: Nefazodone is well-tolerated and is an effective maintenance therapy for chronic forms of MDD...
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phasesMartin B Keller
Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
J Clin Psychiatry 68:1246-56. 2007..To report second-year results from the 2-year maintenance phase of a long-term study to evaluate the efficacy and safety of venlafaxine extended release (ER) in preventing recurrence of depression...
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phasesMartin B Keller
Brown University, Providence, Rhode Island 02906, USA
Biol Psychiatry 62:1371-9. 2007..We evaluated the comparative efficacy and safety of venlafaxine extended release (ER) and fluoxetine in the acute and continuation phases of treatment...
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP TrialJames H Kocsis
Department of Psychiatry, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, USA
Arch Gen Psychiatry 66:1178-88. 2009..Previous studies have found that few chronically depressed patients remit with antidepressant medications alone...
Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatmentJames H Kocsis
Department of Psychiatry, Weill Cornell Medical Center, 525 East 68th Street, New York, NY 10021, USA
J Affect Disord 110:55-61. 2008..These results and the consistency of similar results over time point to the dire need for patient and provider education regarding the signs and symptoms of depression and its treatment...
Tachyphylaxis in unipolar major depressive disorderDavid A Solomon
Department of Psychiatry and Human Behavior, Brown University, 593 Eddy Street, Providence, RI 02903, USA
J Clin Psychiatry 66:283-90. 2005..This study describes recurrence of major depression despite maintenance pharmacotherapy, termed tachyphylaxis...
Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combinationJohn Zajecka
Department of Psychiatry, Rush-Presbyterian-St. Luke's Medical Center, 1725 W. Harrison Street, Suite 955, Chicago, IL 60612, USA
J Clin Psychiatry 63:709-16. 2002..Treatment with nefazodone, CBASP, and combined treatment improved sexual interest/satisfaction, with greatest improvement observed with combined treatment...
Anxiety sensitivity as a predictor of the clinical course of panic disorder: a 1-year follow-up studyCarlos Israel Pérez Benítez
Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island 02912, USA
Depress Anxiety 26:335-42. 2009..The main purpose of this study was to examine whether NA and AS will also predict the clinical course of PD...
Preliminary findings regarding overweight and obesity in pediatric bipolar disorderBenjamin I Goldstein
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
J Clin Psychiatry 69:1953-9. 2008..Overweight/obesity is highly prevalent among adults with bipolar disorder and has been associated with illness severity. Little is known regarding overweight/obesity among youth with bipolar disorder...
Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combinationJames H Kocsis
Department of Psychiatry, Weill Cornell Medical College, New York, NY 10021, USA
Psychopharmacol Bull 37:73-87. 2003..COMB was associated with less symptom re-emergence during the continuation phase than either monotherapy, particularly for partial remitters...
Significance of cigarette smoking among youths with bipolar disorderBenjamin I Goldstein
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
Am J Addict 17:364-71. 2008..Daily heavy smokers had greater prevalence of SUD and suicide attempts, and worse depression versus daily light smokers. Smoking among youths with BP is independently associated with suicide attempts and SUD...
Comorbid anxiety in children and adolescents with bipolar spectrum disorders: prevalence and clinical correlatesRegina Sala
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
J Clin Psychiatry 71:1344-50. 2010..Anxiety disorders are among the most common comorbid conditions in youth with bipolar disorder. We aimed to examine the prevalence and correlates of comorbid anxiety disorders among youth with bipolar disorder...
Antidepressants and risks of suicide and suicide attempts: a 27-year observational studyAndrew C Leon
Department of Psychiatry, Weill Cornell Medical College, New York, NY 10065, USA
J Clin Psychiatry 72:580-6. 2011..The objective of this study was to examine the association of antidepressants with suicide attempts and with suicide deaths...
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT StudyJames H Kocsis
Department of Psychiatry, Weill Cornell Medical College, New York, NY 10012, USA
J Clin Psychiatry 68:1014-23. 2007..To test the long-term efficacy and safety of venlafaxine extended-release (ER) in preventing recurrence in patients with major depression...
Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal studyLewis L Judd
Department of Psychiatry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093 0603, USA
Arch Gen Psychiatry 62:1322-30. 2005..Evidence of psychosocial disability in bipolar disorder is based primarily on bipolar I disorder (BP-I) and does not relate disability to affective symptom severity and polarity or to bipolar II disorder (BP-II)...
Mental health treatment received by primary care patients with posttraumatic stress disorderBenjamin F Rodriguez
Department of Psychiatry and Human Behavior, Brown University Medical School, Providence, R I, USA
J Clin Psychiatry 64:1230-6. 2003..Our purpose was to describe the characteristics of mental health treatment received by primary care patients diagnosed with PTSD...
Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective studySteven E Bruce
Department of Psychiatry and Human Behavior, Brown University, RI 02906, USA
Am J Psychiatry 162:1179-87. 2005....
Distinguishing bipolar major depression from unipolar major depression with the screening assessment of depression-polarity (SAD-P)David A Solomon
Department of Psychiatry and Human Behavior, Brown University, Providence, RI, USA
J Clin Psychiatry 67:434-42. 2006..The goal of this study was to develop and validate a brief instrument to screen for bipolar disorder in patients actively ill with major depression...
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatientsA John Rush
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
Neuropsychopharmacology 30:405-16. 2005..Global patient ratings such as the PGI-I, as opposed to specific item-based ratings, provide less valid findings...
A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorderLewis L Judd
Department of Psychiatry, University of California, San Diego, La Jolla 92093-0603, USA
Arch Gen Psychiatry 60:261-9. 2003..Longitudinally, BP-II is expressed as a dimensional illness involving the full severity range of depressive and hypomanic symptoms. Hypomania of long or short duration in BP-II seems to be part of the same disease process...
Course of illness following prospectively observed mania or hypomania in individuals presenting with unipolar depressionJess G Fiedorowicz
Department of Psychiatry, Roy J and Lucille A Carver College of Medicine, The University of Iowa, 200 Hawkins Drive, W278GH Iowa City, IA 52242, USA
Bipolar Disord 14:664-71. 2012..In a well-defined sample, we sought to determine which clinical variables, some of potential nosological relevance, influence subsequent course following prospectively observed initial episodes of hypomania or mania (H/M)...
Social anxiety disorder clinical course and outcome: review of Harvard/Brown Anxiety Research Project (HARP) findingsMartin B Keller
Department of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, RI 02912, USA
J Clin Psychiatry 67:14-9. 2006..Whereas, the relapse rate, once recovery is achieved, is 34% during this 10-year follow-up. Treatment is underutilized in patients with SAD, and a long-term treatment approach may be needed to improve the likelihood of recovery from SAD...
Is anyone really M.A.D.?: the occurrence and course of mixed anxiety-depressive disorder in a sample of primary care patientsRisa B Weisberg
Department of Psychiatry, Brown University, Providence, Rhode Island 02912, USA
J Nerv Ment Dis 193:223-30. 2005..Although this was not a prevalence study, results indicate a very low occurrence of MAD across 15 primary care settings. Further, they indicate that this diagnosis may not be stable across time and raise doubts about its utility...
Characteristics and predictors of social phobia course in a longitudinal study of primary-care patientsCourtney Beard
Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI 02912, USA
Depress Anxiety 27:839-45. 2010..To date, few researchers have examined the natural course of SP in primary care. We examined the natural course and predictors of recovery in a large sample of primary-care patients...
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depressionA John Rush
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9086, USA
Biol Psychiatry 54:573-83. 2003..The QIDS-SR(16) has highly acceptable psychometric properties, which supports the usefulness of this brief rating of depressive symptom severity in both clinical and research settings...
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depressionMichael E Thase
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, PA 15213 2593, USA
J Clin Psychiatry 63:493-500. 2002..As nefazodone-mediated blockade of serotonin-2 receptors may directly relieve insomnia associated with depression, we examined the more specific effects of CBASP and nefazodone, singly and in combination, on sleep disturbances...
REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and designMadhukar H Trivedi
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA
Psychopharmacol Bull 41:5-33. 2008....
Chronicity in posttraumatic stress disorder and predictors of the course of posttraumatic stress disorder among primary care patientsCaron Zlotnick
Butler Hospital, Providence, RI 02906, USA
J Nerv Ment Dis 192:153-9. 2004..e., full and partial PTSD). This study suggests that, in a primary care setting, PTSD is a persistent illness, and that many subjects who have recovered from PTSD continue to suffer from subthreshold symptoms of PTSD...
Psychiatric treatment in primary care patients with anxiety disorders: a comparison of care received from primary care providers and psychiatristsRisa B Weisberg
Department of Psychiatry, Brown University, Providence, RI 02096, USA
Am J Psychiatry 164:276-82. 2007..This study examined psychiatric treatment received by primary care patients with anxiety disorders and compared treatment received from primary care physicians and from psychiatrists...
Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disordersTimothy I Mueller
Southern Arizona VA Health Care System, University of Arizona Health Sciences Center, Department of Psychiatry, Tucson, Arizona 85723, USA
Alcohol Clin Exp Res 29:1411-8. 2005..Earlier research showed that the use of benzodiazepines was not significantly associated with the presence or absence of a history of an AUD over the first year of follow-up. This report extends that investigation...
Psychosocial impairment and recurrence of major depressionDavid A Solomon
Department of Psychiatry and Human Behavior, Brown University, Providence, RI, USA
Compr Psychiatry 45:423-30. 2004..In patients who have recovered from an episode of major depression, the presence of psychosocial impairment may help identify who is at increased risk of recurrence...
Irritability and elation in a large bipolar youth sample: relative symptom severity and clinical outcomes over 4 yearsJeffrey I Hunt
Department of Psychiatry and Human Behavior, Emma Pendleton Bradley Hospital, Providence, RI, USA
J Clin Psychiatry 74:e110-7. 2013....
Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: a 30-year observational studyAndrew C Leon
Department of Psychiatry, Weill Cornell Medical College, New York, USA
Am J Psychiatry 169:285-91. 2012..The present study examines the hypothesis that the three antiepileptics approved for bipolar disorder (carbamazepine, lamotrigine, and valproate) are associated with an elevated risk of suicide attempts and suicides...
Effects of anxiety on the long-term course of depressive disordersWilliam Coryell
Department of Psychiatry, Roy J and Lucille A Carver College of Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins, Iowa City, IA 52242, USA
Br J Psychiatry 200:210-5. 2012..Important questions remain as to which anxiety features are important to outcome and how sustained their prognostic effects are over time...
Prevalence and impact of comorbid anxiety and bipolar disorderMartin B Keller
Department of Psychiatry and Human Behavior, Butler Hospital, Providence, RI 02906, USA
J Clin Psychiatry 67:5-7. 2006..Because the degree to which anxiety impacts patients with bipolar disorder is not fully known, more information is needed about the relationship between bipolar disorder and anxiety...
Health-related Quality of Life across the anxiety disorders: findings from a sample of primary care patientsCourtney Beard
Alpert Medical School of Brown University, Department of Psychiatry and Human Behavior, Providence, RI 02912, USA
J Anxiety Disord 24:559-64. 2010..The current study extends previous research by showing that different anxiety disorders and comorbid conditions may be associated with impairment in specific domains of HR-QoL...
Empirical typology of bipolar I mood episodesDavid A Solomon
Department of Psychiatry, Rhode Island Hospital, 593 Eddy Street, Providence, Rhode Island 02903 4970, USA
Br J Psychiatry 195:525-30. 2009..Much remains unknown about the phenomenology of bipolar I disorder...
Issues in treatment-resistant depressionMartin B Keller
Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02912, USA
J Clin Psychiatry 66:5-12. 2005..Electroconvulsive therapy and psychotherapy offer additional treatment strategies. New nonpharmacologic therapies are under investigation. Remission is the goal of treatment...
The Child Behavior Checklist (CBCL) and the CBCL-bipolar phenotype are not useful in diagnosing pediatric bipolar disorderRasim Somer Diler
Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
J Child Adolesc Psychopharmacol 19:23-30. 2009..The purpose of this study was to evaluate the usefulness of the CBCL and CBCL-PBD to identify BP in children <12 years old...
Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective studyCarlos Israel Pérez Benítez
Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02912, USA
Am J Geriatr Psychiatry 16:5-13. 2008....
The relationship between sleep disturbance and the course of anxiety disorders in primary care patientsBrook A Marcks
Warren Alpert School of Medicine at Brown University, Department of Psychiatry and Human Behavior, Providence, RI 02912, USA
Psychiatry Res 178:487-92. 2010..The findings suggest that sleep disturbance in PTSD may have prognostic significance and may be important to address in clinical interventions...
Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?Steven E Bruce
Brown University, Providence, RI 02906, USA
Am J Psychiatry 160:1432-8. 2003..The authors examined how the use of psychotropic drugs has shifted over the course of 10 years to determine if prescribing patterns have changed to reflect these revised treatment guidelines...
Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-upKimberly A Yonkers
Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut 06510, USA
Depress Anxiety 17:173-9. 2003..It may be that sex differences in the clinical course of anxiety disorders hold prognostic implications for patients with these illnesses...
Impact of parental history of substance use disorders on the clinical course of anxiety disordersMaria E Pagano
Department of Psychiatry, Division of Child Psychiatry, Case Western Reserve University, Euclid Avenue, Cleveland, OH, USA
Subst Abuse Treat Prev Policy 2:13. 2007..The purpose of this study was to examine prospectively the relationship between parental substance use disorders and the course of anxiety disorders in adulthood over the course of 12 years...
The clinical course of body dysmorphic disorder in the Harvard/Brown Anxiety Research Project (HARP)Andri S Bjornsson
Rhode Island Hospital, Coro Center West, 1 Hoppin St, Providence, RI 02903, USA
J Nerv Ment Dis 199:55-7. 2011..14 over the 8 years. In conclusion, among individuals ascertained for anxiety disorders, the probability of recovering from BDD was relatively high and probability of BDD recurrence was low...
The impact of stressful life events on relapse of generalized anxiety disorderJennifer L Francis
Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA
Depress Anxiety 29:386-91. 2012..This study examined the impact of SLEs on relapse in adults already diagnosed with GAD...
Substance use disorders among adolescents with bipolar spectrum disordersBenjamin I Goldstein
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
Bipolar Disord 10:469-78. 2008..We set out to examine the prevalence and correlates of substance use disorders (SUD) in a large sample of adolescents with bipolar disorder (BP)...
Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United StatesCharles B Nemeroff
Department of Psychiatry, Emory University School of Medicine, Atlanta, GA, USA
Arch Gen Psychiatry 64:466-72. 2007....
Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findingsBetsy D Kennard
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 8589, USA
J Consult Clin Psychol 77:1033-41. 2009..Finally, social skills and problem solving may be active elements in CBT for adolescent depression and should be considered in treatment by those working with seriously depressed youths...
Psychiatric treatment received by primary care patients with panic disorder with and without agoraphobiaBrook A Marcks
Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Box G BH, Duncan Bldg, Providence, RI 02912, USA
Psychiatr Serv 60:823-30. 2009....
The long-term natural history of the weekly symptomatic status of bipolar I disorderLewis L Judd
Department of Psychiatry, University of California-San Diego, La Jolla, CA 92093-0603, USA
Arch Gen Psychiatry 59:530-7. 2002..Symptom severity levels fluctuate, often within the same patient over time. Bipolar I disorder is expressed as a dimensional illness featuring the full range (spectrum) of affective symptom severity and polarity...
Social and health functioning in female primary care patients with post-traumatic stress disorder with and without comorbid substance abuseCaron Zlotnick
Butler Hospital, Providence, RI, USA
Compr Psychiatry 44:177-83. 2003..These findings suggest that the presence of comorbid SUD may not explain the level of social and health difficulties associated with the dual diagnosis of PTSD and SUD...
The course of depression in elderly patientsTimothy I Mueller
Brown University Medical School, Department of Psychiatry and Human Behavior, c o Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, USA
Am J Geriatr Psychiatry 12:22-9. 2004..Studies on the course of major depressive disorder (MDD) among elderly persons are limited to short periods of follow-up, seldom provide comparisons with younger cohorts, and raise other methodological concerns...
Depression treatment: a lifelong commitment?Martin B Keller
Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
Psychopharmacol Bull 36:133-41. 2002..Additional well-designed studies addressing these issues are urgently needed...
Unipolar mania over the course of a 20-year follow-up studyDavid A Solomon
NIMH Collaborative Program on the Psychobiology of Depression Clinical Studies, at Mood Disorders Program, Department of Psychiatry, Rhode Island Hospital, 593 Eddy Street, Providence RI 02903 4970, USA
Am J Psychiatry 160:2049-51. 2003..Using data from a longitudinal study of the mood disorders, the investigators address the phenomenon of unipolar mania...
Do panic symptoms during periods of remission predict relapse of panic disorder?Risa B Weisberg
Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island, 02912, USA
J Nerv Ment Dis 190:190-7. 2002..Thus, although panic symptoms during remission may indicate an increased risk of subsequent relapse, the absence of symptoms during remission does not indicate that relapse is unlikely...
Relapse prevention with gepirone ER in outpatients with major depressionMartin B Keller
Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
J Clin Psychopharmacol 25:79-84. 2005..In conclusion, gepirone ER at a dose range of 40 to 80 mg/d is effective for relapse prevention in patients with recurrent major depression. It is well tolerated during long-term treatment for up to approximately one year...
Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorderAnn O Massion
Department of Psychiatry, University of Massachusetts Medical School, 55 Lake Ave N, Worcester, MA 01655, USA
Arch Gen Psychiatry 59:434-40. 2002..This investigation assessed the effect of personality disorders (PersDs) on time to remission in patients with generalized anxiety disorder, social phobia, or panic disorder...
Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combinationPhilip T Ninan
Department of Psychiatry, Emory University School of Medicine, Atlanta, GA 30329, USA
J Clin Psychiatry 63:434-41. 2002..Among patients with a concurrent anxiety disorder, nefazodone. either alone or in combination with CBASP, improves anxiety symptoms faster than CBASP alone, independent of depressive symptom reduction...
Remission versus response: the new gold standard of antidepressant careMartin B Keller
Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
J Clin Psychiatry 65:53-9. 2004..This dynamic is reinforced via the integration of current best therapeutic thinking in research settings, leading to clinical trials that more closely approximate an ideal, remission-focused treatment regimen...
Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyondMartin B Keller
Department of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, RI 02906, USA
JAMA 289:3152-60. 2003..Until then, remission should continue to be based on the descriptive and experiential phenomena of symptoms and psychosocial functioning...
Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuationMark Hyman Rapaport
Department of Psychiatry, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
Neuropsychopharmacology 31:2505-13. 2006..1 and 64.1%, respectively (p < or = 0.05). Open-label risperidone augmentation substantially enhanced response in treatment-resistant patients, but the longer-term benefits of augmentation were not demonstrated in this study...
Improving the course of illness and promoting continuation of treatment of bipolar disorderMartin B Keller
Department of Psychiatry and Human Behavior, Brown University Medical School, Providence, RI 02906, USA
J Clin Psychiatry 65:10-4. 2004..Physicians can help improve adherence by selecting medications with simple dosage regimens and educating patients and families about the disorder and what to expect from medications...
Predictors of treatment utilization among women with anorexia and bulimia nervosaPamela K Keel
Department of Psychiatry, Massachusetts General Hospital, Boston, USA
Am J Psychiatry 159:140-2. 2002..CONCLUSIONS: Women with more severe pathology have higher treatment utilization rates. This pattern may explain the seeming lack of treatment efficacy for eating disorders outside of randomized controlled studies...
Short-term diagnostic stability of schizotypal, borderline, avoidant, and obsessive-compulsive personality disordersM Tracie Shea
Department of Psychiatry and Human Behavior, Brown University Medical School, Duncan Building, 700 Butler Drive, Providence, RI 20906, USA
Am J Psychiatry 159:2036-41. 2002..Personality disorders may be characterized by stable trait constellations that fluctuate in degree of maladaptive expression...
Key considerations in choosing an antidepressantMartin B Keller
Department of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, RI 02912, USA
Postgrad Med 114:10-8. 2003..Thus, it is critical to stay up to date with the best therapeutic approach, while remaining flexible as new therapies are developed...
Raising the expectations of long-term treatment strategies in anxiety disordersMartin B Keller
Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
Psychopharmacol Bull 36:166-74. 2002..Future studies should emphasize the role of preventive pharmacotherapy to improve the long-term course of anxiety and to reduce its associated suffering, suicide, and occupational and social impairment...
Rationale and options for the long-term treatment of depressionMartin B Keller
Brown University, Providence, Rhode Island 02906-4871, USA
Hum Psychopharmacol 17:S43-6. 2002..It is also well tolerated over prolonged periods. It should therefore prove suitable for use as maintenance treatment in depressed patients...
Long-term treatment strategies in affective disordersMartin B Keller
Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
Psychopharmacol Bull 36:36-48. 2002..The significantly higher remission rates attained with venlafaxine treatment as compared with some SSRIs warrant further studies of SNRIs for the long-term treatment of depression...
Nonpsychiatric illness among primary care patients with trauma histories and posttraumatic stress disorderRisa B Weisberg
Department of Psychiatry and Human Behavior at Brown University in Providence, Rhode Island 02912, USA
Psychiatr Serv 53:848-54. 2002..The authors examined the relationship between posttraumatic stress disorder (PTSD), trauma, and self-reported nonpsychiatric medical conditions in a sample of 502 primary care patients with one or more anxiety disorders...
Paroxetine treatment of major depressive disorderMartin B Keller
Department of Psychiatry, Brown University, Providence, RI 02906, USA
Psychopharmacol Bull 37:42-52. 2003....
Long-term treatment of patients with recurrent unipolar major depression: evidence to clinical practiceMartin B Keller
Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
CNS Spectr 11:4-5. 2006
Factor structure and stability of the Anxiety Sensitivity Index in a longitudinal study of anxiety disorder patientsBenjamin F Rodriguez
Brown University Medical School, Department of Psychiatry and Human Behavior, Box G BH Duncan Building, Providence RI 02912, USA
Behav Res Ther 42:79-91. 2004..The theoretical implications of these findings for future evaluations of anxiety sensitivity are discussed...
Therapeutic alliance in depression treatment: controlling for prior change and patient characteristicsDaniel N Klein
Department of Psychology and Psychiatry, State University of New York at Stony Brook, 11794 2500, USA
J Consult Clin Psychol 71:997-1006. 2003..Patients receiving combination treatment reported stronger alliances with their psychotherapists than patients receiving CBASP alone. However, the impact of the alliance on outcome was similar for both treatment conditions...
Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapseAndrew A Nierenberg
Havard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA
Neuropsychopharmacology 29:1012-8. 2004..The low relapse rate for patients with an acute placebo pattern switched to placebo suggests specific drug effect played a smaller role in their initial improvement...
Characteristics and predictors of full and partial recovery from generalized anxiety disorder in primary care patientsBenjamin F Rodriguez
Department of Psychology, Southern Illinois University at Carbondale, Carbondale, IL 62901-6502, USA
J Nerv Ment Dis 194:91-7. 2006..These results underscore that GAD is a chronic and persistent illness in primary care patients...
Untangling depression and anxiety: clinical challengesMartin B Keller
J Clin Psychiatry 66:1477-84. 2005
Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobiaRussell G Vasile
Beth Israel Deaconess Medical Center, Boston, Massachusetts
Depress Anxiety 22:59-67. 2005..Difficulties in the implementation of treatment guidelines are discussed...
Relationships among psychosocial functioning, diagnostic comorbidity, and the recurrence of generalized anxiety disorder, panic disorder, and major depressionBenjamin F Rodriguez
Department of Psychology, Southern Illinois University, Life Sciences II Room 222A, Carbondale, IL 62901 6502, USA
J Anxiety Disord 19:752-66. 2005..The Journal of Nervous and Mental Disease, 188, 805-812], and suggest that increased psychosocial impairment may be a risk factor for relapse...
Predicting recovery from episodes of major depressionDavid A Solomon
Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Providence, RI 02903 4970, United States
J Affect Disord 107:285-91. 2008..This study examined psychosocial functioning as a predictor of recovery from episodes of unipolar major depression...
The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders?Lewis L Judd
National Institute of Mental Health Collaborative Program on the Psychobiology of Depression Clinical Studies, USA
J Affect Disord 73:19-32. 2003....
A 20-year longitudinal observational study of somatic antidepressant treatment effectivenessAndrew C Leon
NIMH Collaborative Program on the Psychobiology of Depression, USA
Am J Psychiatry 160:727-33. 2003..This observational study examined the effectiveness of somatic antidepressant treatments as administered in the community...
Chronic depression and comorbid personality disorders: response to sertraline versus imipramineJames M Russell
Department of Psychiatry and Behavioral Sciences, The University of Texas Medical Branch at Galveston, 77555, USA
J Clin Psychiatry 64:554-61. 2003..Few studies, though, have systematically examined the clinical correlates of Axis II personality disorder comorbidity or its effect on treatment response or time to response...
The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medicationAlan J Gelenberg
University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
J Clin Psychiatry 65:1114-9. 2004..A continuation study of an extract of St. John's wort (Hypericum perforatum) for depression was performed in follow-up to an acute study that found no significant difference between St. John's wort extract and placebo...
Frequency and patterns of psychiatric comorbidity in a sample of primary care patients with anxiety disordersBenjamin F Rodriguez
Department of Psychology, Southern Illinois University-Carbondale, Life Science II, Room 281, Mailcode 6502, Carbondale, IL 62901, USA
Compr Psychiatry 45:129-37. 2004..2001). Implications of these results for both the mental health and primary care fields are also discussed...
Group comparisons of DSM-IV subtypes of chronic depression: validity of the distinctions, part 2James P McCullough
Department of Psychology, Virginia Commonwealth University, Richmond, VA 23284 2018, USA
J Abnorm Psychol 112:614-22. 2003..The authors suggest that chronic depression should be viewed as a single, broad condition that can assume a variety of clinical course configurations...
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood traumaCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322
Proc Natl Acad Sci U S A 100:14293-6. 2003..Our results suggest that psychotherapy may be an essential element in the treatment of patients with chronic forms of major depression and a history of childhood trauma...
Clinical use of nefazodone in major depression: a 6-year perspectiveAlan F Schatzberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Calif 94305-5717, USA
J Clin Psychiatry 63:18-31. 2002
